Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al.

Ítems similars

• The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
  per: Zhou, Haiyan, et al.
  Publicat: (2020)
• The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
  per: Haiyan Zhou, et al.
  Publicat: (2020-10-01)
• Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
  per: Zhou, Haiyan, et al.
  Publicat: (2020)
• Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy
  per: Porensky, Paul N., et al.
  Publicat: (2013)
• Antisense oligonucleotides and spinal muscular atrophy: skipping along
  per: Burghes, Arthur H.M., et al.
  Publicat: (2010)